Related Experiment Video

Updated: Apr 3, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.9K

Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists

Shawn T Beug1, David P Conrad, Tommy Alain

  • 1Solange Gauthier Karsh Molecular Genetics Laboratory, Apoptosis Research Centre, Children's Hospital of Eastern Ontario (CHEO) Research Institute, Ottawa, Canada.

The International Journal of Developmental Biology
|September 17, 2015
PubMed

Insights

Smac mimetics, targeting inhibitor of apoptosis proteins (IAPs), enhance cancer immunotherapy. Combining Smac mimetics with agents like interferon or oncolytic viruses offers novel strategies to overcome tumor resistance and improve cancer treatment outcomes.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Inhibitor of Apoptosis (IAP) proteins regulate innate immunity, cell death, and tumorigenesis.
  • Smac (second mitochondria-derived activator of caspases) is an endogenous IAP inhibitor released during cell death.
  • Current cancer therapies using cytokines are limited by adverse effects.

Purpose of the Study:

  • To explore Smac mimetics as novel cancer therapeutics.
  • To investigate combination strategies involving Smac mimetics and immune-stimulating agents.
  • To enhance tumor cell sensitivity to apoptosis and improve anti-cancer therapy.

Main Methods:

  • Development of small molecule Smac mimetics targeting IAPs (cIAP1, cIAP2, XIAP, Livin).
  • Preclinical studies combining Smac mimetics with oncolytic viruses, Toll-like receptor agonists, and recombinant interferon.
  • Analysis of immune-mediated death pathways and tumor cell apoptosis.

Main Results:

  • Smac mimetics modulate immune signaling pathways, increasing tumor cell sensitivity to cytokine-mediated apoptosis.
  • Combination of Smac mimetics with interferon shows synergistic anti-cancer effects.
  • Alternative therapeutic regimens avoid limitations of exogenously delivered death ligands.

Conclusions:

  • Smac mimetics represent a promising therapeutic avenue for cancer treatment.
  • Combinatorial approaches involving Smac mimetics and immune modulation offer new strategies for anti-cancer therapy.
  • Targeting IAPs and immune-mediated death pathways provides a dual-pronged approach to combat cancer.

More Related Videos

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.3K
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells10:04

Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells

Published on: August 1, 2025

2.0K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K